Viroporins: Structure and biological functions

Nature Reviews Microbiology

Volumn 10, Issue 8, 2012, Pages 563-574

  Nieva, José Luis ^a   Madan, Vanesa ^b   Carrasco, Luis ^c  

^a CSIC UPV Unidad de Biofisica UBF   (Spain)

^b UNIVERSITY OF HEIDELBERG   (Germany)

^c UNIVERSIDAD AUTÓNOMA DE MADRID   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

4,4' DIISOTHIOCYANATOSTILBENE 2,2' DISULFONIC ACID; 5 (N,N HEXAMETHYLENE)AMILORIDE; AMANTADINE; BIT 225; CALCIUM; ENVELOPE PROTEIN; IMINOSUGAR; N (5 (1 METHYL 1H PYRAZOL 4 YL)NAPHTHALENE 2 CARBONYL)GUANIDINE; N NONYL DEOXYGALACTONOJIRIMYCIN; N NONYL DEOXYNOJIRIMYCIN; PROTEIN M2; PROTEIN P2B; PROTEIN P7; UNCLASSIFIED DRUG; UT 231B; VIROPORIN; VIRUS GLYCOPROTEIN; VIRUS PROTEIN; VPU PROTEIN;

AMINO TERMINAL SEQUENCE; ANIMAL VIRUS; CALCIUM HOMEOSTASIS; CARBOXY TERMINAL SEQUENCE; CELL MEMBRANE; DRUG TARGETING; HEPATITIS C VIRUS; HOST CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HYDROPHILICITY; HYDROPHOBICITY; INFLUENZA VIRUS A; MEMBRANE PERMEABILITY; NONHUMAN; OLIGOMERIZATION; PICORNAVIRUS; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN FAMILY; PROTEIN MOTIF; PROTEIN STABILITY; PROTEIN STRUCTURE; REVIEW; RNA VIRUS; SARS CORONAVIRUS; VIROGENESIS; VIRUS VIRULENCE;

ANIMALS; CELL MEMBRANE; HEPACIVIRUS; HIV-1; HUMAN IMMUNODEFICIENCY VIRUS PROTEINS; HUMANS; INFLUENZA A VIRUS; MODELS, BIOLOGICAL; PORINS; PROTEIN MULTIMERIZATION; VIRAL MATRIX PROTEINS; VIRAL PROTEINS; VIRAL REGULATORY AND ACCESSORY PROTEINS;

ANIMALIA; HEPATITIS C VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1; INFLUENZA A VIRUS;

EID: 84863981448     PISSN: 17401526     EISSN: 17401534     Source Type: Journal    
DOI: 10.1038/nrmicro2820     Document Type: Review

References (139)

1. Carrasco, L. Modification of membrane permeability by animal viruses. Adv. Virus Res. 45, 61-112 (1995).
2. Gonzalez, M. E. & Carrasco, L. Viroporins. FEBS Lett. 552, 28-34 (2003).
3. Hout, D. R. et al. Vpu: A multifunctional protein that enhances the pathogenesis of human immunodeficiency virus type 1. Curr. HIV Res. 2, 255-270 (2004).
4. Griffin, S. D. Plugging the holes in hepatitis C virus antiviral therapy. Proc. Natl Acad. Sci. USA 106, 12567-12568 (2009).
5. Wang, J., Qiu, J. X., Soto, C. & DeGrado, W. F. Structural and dynamic mechanisms for the function and inhibition of the M2 proton channel from influenza A virus. Curr. Opin. Struct. Biol. 21, 68-80 (2011).
6. Fischer, W. B. & Hsu, H. J. Viral channel forming proteins-modeling the target. Biochim. Biophys. Acta 1808, 561-571 (2011).
7. Carrasco, L. Membrane leakiness after viral infection and a new approach to the development of antiviral agents. Nature 272, 694-699 (1978).
8. Carrasco, L. & Smith, A. E. Sodium ions and the shut-off of host cell protein synthesis by picornaviruses. Nature 264, 807-809 (1976).
9. Lama, J. & Carrasco, L. Expression of poliovirus nonstructural proteins in Escherichia coli cells. Modification of membrane permeability induced by 2B and 3A. J. Biol. Chem. 267, 15932-15937 (1992).
10. Doedens, J. R. & Kirkegaard, K. Inhibition of cellular protein secretion by poliovirus proteins 2B and 3A. EMBO J. 14, 894-907 (1995).
11. Aldabe, R., Barco, A. & Carrasco, L. Membrane permeabilization by poliovirus proteins 2B and 2BC. J. Biol. Chem. 271, 23134-23137 (1996).
12. Aldabe, R., Irurzun, A. & Carrasco, L. Poliovirus protein 2BC increases cytosolic free calcium concentrations. J. Virol. 71, 6214-6217 (1997).
13. van Kuppeveld, F. J. et al. Coxsackievirus protein 2B modifies endoplasmic reticulum membrane and plasma membrane permeability and facilitates virus release. EMBO J. 16, 3519-3532 (1997).
14. Barco, A. & Carrasco, L. A human virus protein, poliovirus protein 2BC, induces membrane proliferation and blocks the exocytic pathway in the yeast Saccharomyces cerevisiae. EMBO J. 14, 3349-3364 (1995).
15. Pinto, L. H., Holsinger, L. J. & Lamb, R. A. Influenza virus M2 protein has ion channel activity. Cell 69, 517-528 (1992).
16. Sakaguchi, T., Leser, G. P. & Lamb, R. A. The ion channel activity of the influenza virus M2 protein affects transport through the Golgi apparatus. J. Cell Biol. 133, 733-747 (1996).
17. Pinto, L. H. & Lamb, R. A. The M2 proton channels of influenza A and B viruses. J. Biol. Chem. 281, 8997-9000 (2006).
18. Pielak, R. M. & Chou, J. J. Influenza M2 proton channels. Biochim. Biophys. Acta 1808, 522-529 (2011).
19. Melton, J. V. et al. Alphavirus 6K proteins form ion channels. J. Biol. Chem. 277, 46923-46931 (2002).
20. Sanz, M. A., Madan, V., Carrasco, L. & Nieva, J. L. Interfacial domains in Sindbis virus 6K protein. Detection and functional characterization. J. Biol. Chem. 278, 2051-2057 (2003).
21. Sanz, M. A., Madan, V., Nieva, J. L. & Carrasco, L. in Viral Membrane Proteins: Structure, Function, and Drug Design (ed. Fischer, W.) 233-244 (Kluwer Academic/Plenum Publishers, 2005).
22. Park, S. H. et al. Three-dimensional structure of the channel-forming trans-membrane domain of virus protein "u" (Vpu) from HIV 1. J. Mol. Biol. 333, 409-424 (2003).
23. Neil, S. J., Zang, T. & Bieniasz, P. D. Tetherin inhibits retrovirus release and is antagonized by HIV 1 Vpu. Nature 451, 425-430 (2008).
24. Griffin, S. D. et al. The p7 protein of hepatitis C virus forms an ion channel that is blocked by the antiviral drug, Amantadine. FEBS Lett. 535, 34-38 (2003).
25. Pavlovic, D. et al. The hepatitis C virus p7 protein forms an ion channel that is inhibited by long-alkyl-chain iminosugar derivatives. Proc. Natl Acad. Sci. USA 100, 6104-6108 (2003).
26. Jones, C. T., Murray, C. L., Eastman, D. K., Tassello, J. & Rice, C. M. Hepatitis C virus p7 and NS2 proteins are essential for production of infectious virus. J. Virol. 81, 8374-8383 (2007).
27. Steinmann, E. et al. Hepatitis C virus p7 protein is crucial for assembly and release of infectious virions. PLoS Pathog. 3, 962-971 (2007).
28. Steinmann, E. et al. Antiviral effects of amantadine and iminosugar derivatives against hepatitis C virus. Hepatology 46, 330-338 (2007).
29. Luik, P. et al. The 3 dimensional structure of a hepatitis C virus p7 ion channel by electron microscopy. Proc. Natl Acad. Sci. USA 106, 12712-12716 (2009).
30. Van Damme, N. et al. The interferon-induced protein BST 2 restricts HIV 1 release and is downregulated from the cell surface by the viral Vpu protein. Cell Host Microbe 3, 245-252 (2008).
31. Cady, S. D. et al. Structure of the amantadine binding site of influenza M2 proton channels in lipid bilayers. Nature 463, 689-692 (2010).
32. Wozniak, A. L. et al. Intracellular proton conductance of the hepatitis C virus p7 protein and its contribution to infectious virus production. PLoS Pathog. 6, e1001087 (2010).
33. Ewart, G. D., Mills, K., Cox, G. B. & Gage, P. W. Amiloride derivatives block ion channel activity and enhancement of virus-like particle budding caused by HIV 1 protein Vpu. Eur. Biophys. J. 31, 26-35 (2002).
34. Watanabe, S., Watanabe, T. & Kawaoka, Y. Influenza A virus lacking M2 protein as a live attenuated vaccine. J. Virol. 83, 5947-5950 (2009).
35. Dube, M., Bego, M. G., Paquay, C. & Cohen, E. A. Modulation of HIV 1 host interaction: role of the Vpu accessory protein. Retrovirology 7, 114 (2010).
36. Lu, W. et al. Severe acute respiratory syndrome-associated coronavirus 3a protein forms an ion channel and modulates virus release. Proc. Natl Acad. Sci. USA 103, 12540-12545 (2006).
37. Gonzalez, M. E. & Carrasco, L. Human immunodeficiency virus type 1 VPU protein affects Sindbis virus glycoprotein processing and enhances membrane permeabilization. Virology 279, 201-209 (2001).
38. Brohm, C. et al. Characterization of determinants important for hepatitis C virus p7 function in morphogenesis by using trans-complementation. J. Virol. 83, 11682-11693 (2009).
39. Hout, D. R. et al. Substitution of the transmembrane domain of Vpu in simian-human immunodeficiency virus (SHlVKu1bMC33) with that of M2 of influenza A results in a virus that is sensitive to inhibitors of the M2 ion channel and is pathogenic for pig-tailed macaques. Virology 344, 541-559 (2006).
40. Carrasco, L., Guinea, R., Irurzun, A. & Barco, A. in Molecular Biology of Picornaviruses (eds Semler, B. L. & Wimmer, E.) 337-354 (American Society for Microbiology Press, 2002).
41. Madan, V., Redondo, N. & Carrasco, L. Cell permeabilization by poliovirus 2B viroporin triggers bystander permeabilization in neighbouring cells through a mechanism involving gap junctions. Cell. Microbiol. 12, 1144-1157 (2010).
42. Han, Z. Y. & Harty, R. N. The NS3 protein of bluetongue virus exhibits viroporin-like properties. J. Biol. Chem. 279, 43092-43097 (2004).
43. Madan, V., Sanz, M. A. & Carrasco, L. Requirement of the vesicular system for membrane permeabilization by Sindbis virus. Virology 332, 307-315 (2005).
44. Liu, D. X., Yuan, Q. & Liao, Y. Coronavirus envelope protein: a small membrane protein with multiple functions. Cell. Mol. Life Sci. 64, 2043-2048 (2007).
45. Han, Z. Y., Licata, J. M., Paragas, J. & Harty, R. N. Permeabilization of the plasma membrane by Ebola virus GP2. Virus Genes 34, 273-281 (2007).
46. Suzuki, T. et al. The human polyoma JC virus agnoprotein acts as a viroporin. PLoS Pathog. 6, e1000801 (2010).
47. Agirre, A., Barco, A., Carrasco, L. & Nieva, J. L. Viroporin-mediated membrane permeabilization. Pore formation by nonstructural poliovirus 2B protein. J. Biol. Chem. 277, 40434-40441 (2002).
48. Fischer, W. B. & Kruger, J. Viral channel-forming proteins. Int. Rev. Cell. Mol. Biol. 275, 35-63 (2009).
49. Pinto, L. H. et al. A functionally defined model for the M2 proton channel of influenza A virus suggests a mechanism for its ion selectivity. Proc. Natl Acad. Sci. USA 94, 11301-11306 (1997).
50. Schubert, U. et al. Identification of an ion channel activity of the Vpu transmembrane domain and its involvement in the regulation of virus release from HIV 1 infected cells. FEBS Lett. 398, 12-18 (1996).
51. Mehnert, T. et al. Biophysical characterization of Vpu from HIV 1 suggests a channel-pore dualism. Proteins 70, 1488-1497 (2008).
52. Madan, V., Castello, A. & Carrasco, L. Viroporins from RNA viruses induce caspase-dependent apoptosis. Cell. Microbiol. 10, 437-451 (2008).
53. Gonzalez, M. E. & Carrasco, L. The human immunodeficiency virus type 1 Vpu protein enhances membrane permeability. Biochemistry 37, 13710-13719 (1998).
54. Clarke, D. et al. Evidence for the formation of a heptameric ion channel complex by the hepatitis C virus p7 protein in vitro. J. Biol. Chem. 281, 37057-37068 (2006).
55. Madan, V., Garcia Mde, J., Sanz, M. A. & Carrasco, L. Viroporin activity of murine hepatitis virus E protein. FEBS Lett. 579, 3607-3612 (2005).
56. Wilson, L., McKinlay, C., Gage, P. & Ewart, G. SARS coronavirus E protein forms cation-selective ion channels. Virology 330, 322-331 (2004).
57. Phillips, R., Ursell, T., Wiggins, P. & Sens, P. Emerging roles for lipids in shaping membrane-protein function. Nature 459, 379-385 (2009).
58. Chami, M., Ferrari, D., Nicotera, P., Paterlini-Brechot, P. & Rizzuto, R. Caspase-dependent alterations of Ca2+ signaling in the induction of apoptosis by hepatitis B virus X protein. J. Biol. Chem. 278, 31745-31755 (2003).
59. de Jong, A. S. et al. Functional analysis of picornavirus 2B proteins: effects on calcium homeostasis and intracellular protein trafficking. J. Virol. 82, 3782-3790 (2008).
60. Hyser, J. M., Collinson-Pautz, M. R., Utama, B. & Estes, M. K. Rotavirus disrupts calcium homeostasis by NSP4 viroporin activity. mBio 1, e00265 10 (2010).
61. van Kuppeveld, F. J., Below, G. & Ehrenfeld, E. in The Picornaviruses (eds Ehrenfeld, E., Domingo, E. & Roos, R. P.) 181-193 (American Society for Microbiology Press, 2010).
62. Diaz, Y. et al. Expression of nonstructural rotavirus protein NSP4 mimics Ca2+ homeostasis changes induced by rotavirus infection in cultured cells. J. Virol. 82, 11331-11343 (2008).
63. Zhou, Y., Frey, T. K. & Yang, J. J. Viral calciomics: interplays between Ca2+ and virus. Cell Calcium 46, 1-17 (2009).
64. Hajnoczky, G., Davies, E. & Madesh, M. Calcium signaling and apoptosis. Biochem. Biophys. Res. Commun. 304, 445-454 (2003).
65. Jacotot, E. et al. The HIV 1 viral protein R induces apoptosis via a direct effect on the mitochondrial permeability transition pore. J. Exp. Med. 191, 33-46 (2000).
66. Hsu, N. Y. et al. Viral reorganization of the secretory pathway generates distinct organelles for RNA replication. Cell 141, 799-811 (2010).
67. Suhy, D. A., Giddings, T. H. Jr & Kirkegaard, K. Remodeling the endoplasmic reticulum by poliovirus infection and by individual viral proteins: an autophagy-like origin for virus-induced vesicles. J. Virol. 74, 8953-8965 (2000).
68. de Jong, A. S. et al. The coxsackievirus 2B protein increases efflux of ions from the endoplasmic reticulum and Golgi, thereby inhibiting protein trafficking through the Golgi. J. Biol. Chem. 281, 14144-14150 (2006).
69. Kirkegaard, K. Subversion of the cellular autophagy pathway by viruses. Curr. Top. Microbiol. Immunol. 335, 323-333 (2009).
70. Ruiz, A., Guatelli, J. C. & Stephens, E. B. The Vpu protein: new concepts in virus release and CD4 down-modulation. Curr. HIV Res. 8, 240-252 (2010).
71. Dube, M. et al. HIV 1 Vpu antagonizes BST 2 by interfering mainly with the trafficking of newly synthesized BST 2 to the cell surface. Traffic 12, 1714-1729 (2011).
72. Martin-Serrano, J. & Neil, S. J. Host factors involved in retroviral budding and release. Nature Rev. Microbiol. 9, 519-531 (2011).
73. Terwilliger, E. F., Cohen, E. A., Lu, Y. C., Sodroski, J. G. & Haseltine, W. A. Functional role of human immunodeficiency virus type 1 vpu. Proc. Natl Acad. Sci. USA 86, 5163-5167 (1989).
74. Iwatsuki-Horimoto, K. et al. The cytoplasmic tail of the influenza A virus M2 protein plays a role in viral assembly. J. Virol. 80, 5233-5240 (2006).
75. Hsu, K., Han, J., Shinlapawittayatorn, K., Deschenes, I. & Marban, E. Membrane potential depolarization as a triggering mechanism for Vpu-mediated HIV 1 release. Biophys. J. 99, 1718-1725 (2010).
76. Huang, D. T., Chi, N., Chen, S. C., Lee, T. Y. & Hsu, K. Background K2P channels KCNK3/9/15 limit the budding of cell membrane-derived vesicles. Cell Biochem. Biophys. 61, 585-594 (2011).
77. Schnell, J. R. & Chou, J. J. Structure and mechanism of the M2 proton channel of influenza A virus. Nature 451, 591-595 (2008).
78. Leiding, T., Wang, J., Martinsson, J., DeGrado, W. F. & Arskold, S. P. Proton and cation transport activity of the M2 proton channel from influenza A virus. Proc. Natl Acad. Sci. USA 107, 15409-15414 (2010).
79. Sharma, M. et al. Insight into the mechanism of the influenza A proton channel from a structure in a lipid bilayer. Science 330, 509-512 (2010).
80. Rossman, J. S., Jing, X., Leser, G. P. & Lamb, R. A. Influenza virus M2 protein mediates ESCRT-independent membrane scission. Cell 142, 902-913 (2010).
81. Carrasco, L. Entry of animal viruses and macromolecules into cells. FEBS Lett. 350, 151-154 (1994).
82. Watanabe, T., Watanabe, S., Ito, H., Kida, H. & Kawaoka, Y. Influenza A virus can undergo multiple cycles of replication without M2 ion channel activity. J. Virol. 75, 5656-5662 (2001).
83. Griffin, S. et al. Genotype-dependent sensitivity of hepatitis C virus to inhibitors of the p7 ion channel. Hepatology 48, 1779-1790 (2008).
84. Fernandez-Puentes, C. & Carrasco, L. Viral infection permeabilizes mammalian cells to protein toxins. Cell 20, 769-775 (1980).
85. Nieva, J. L., Agirre, A., Nir, S. & Carrasco, L. Mechanisms of membrane permeabilization by picornavirus 2B viroporin. FEBS Lett. 552, 68-73 (2003).
86. van Kuppeveld, F. J., Galama, J. M., Zoll, J., van den Hurk, P. J. & Melchers, W. J. Coxsackie B3 virus protein 2B contains cationic amphipathic helix that is required for viral RNA replication. J. Virol. 70, 3876-3886 (1996).
87. van Kuppeveld, F. J., Melchers, W. J., Kirkegaard, K. & Doedens, J. R. Structure-function analysis of coxsackie B3 virus protein 2B. Virology 227, 111-118 (1997).
88. Martinez-Gil, L. et al. Membrane integration of poliovirus 2B viroporin. J. Virol. 85, 11315-11324 (2011).
89. Barco, A. & Carrasco, L. Identification of regions of poliovirus 2BC protein that are involved in cytotoxicity. J. Virol. 72, 3560-3570 (1998).
90. de Jong, A. S. et al. Determinants for membrane association and permeabilization of the coxsackievirus 2B protein and the identification of the Golgi complex as the target organelle. J. Biol. Chem. 278, 1012-1021 (2003).
91. van Kuppeveld, F. J., Melchers, W. J., Willems, P. H. & Gadella, T. W. Jr. Homomultimerization of the coxsackievirus 2B protein in living cells visualized by fluorescence resonance energy transfer microscopy. J. Virol. 76, 9446-9456 (2002).
92. Patargias, G., Barke, T., Watts, A. & Fischer, W. B. Model generation of viral channel forming 2B protein bundles from polio and coxsackie viruses. Mol. Membr. Biol. 26, 309-320 (2009).
93. Ojcius, D. M. & Young, J. D. Cytolytic pore-forming proteins and peptides: is there a common structural motif? Trends Biochem. Sci. 16, 225-229 (1991).
94. Madan, V. et al. Plasma membrane-porating domain in poliovirus 2B protein. A short peptide mimics viroporin activity. J. Mol. Biol. 374, 951-964 (2007).
95. Sanchez-Martinez, S. et al. Functional and structural characterization of 2B viroporin membranolytic domains. Biochemistry 47, 10731-10739 (2008).
96. Hoofnagle, J. H. Course and outcome of hepatitis C. Hepatology 36, S21-S29 (2002).
97. Moradpour, D., Penin, F. & Rice, C. M. Replication of hepatitis C virus. Nature Rev. Microbiol. 5, 453-463 (2007).
98. Steinmann, E. & Pietschmann, T. Hepatitis C virus P7-a viroporin crucial for virus assembly and an emerging target for antiviral therapy. Viruses 2, 2078-2095 (2010).
99. Premkumar, A., Wilson, L., Ewart, G. D. & Gage, P. W. Cation-selective ion channels formed by p7 of hepatitis C virus are blocked by hexamethylene amiloride. FEBS Lett. 557, 99-103 (2004).
100. Montserret, R. et al. NMR structure and ion channel activity of the p7 protein from hepatitis C virus. J. Biol. Chem. 285, 31446-31461 (2010).
101. McCown, M. F. & Pekosz, A. The influenza A virus M2 cytoplasmic tail is required for infectious virus production and efficient genome packaging. J. Virol. 79, 3595-3605 (2005).
102. Ichinohe, T., Pang, I. K. & Iwasaki, A. Influenza virus activates inflammasomes via its intracellular M2 ion channel. Nature Immunol. 11, 404-410 (2010).
103. Ma, H. et al. Human annexin A6 interacts with influenza A virus protein M2 and negatively modulates infection J. Virol. 86, 1789-1901 (2012).
104. Gannage, M. et al. Matrix protein 2 of influenza A virus blocks autophagosome fusion with lysosomes. Cell Host Microbe 6, 367-380 (2009).
105. Cordes, F. S., Tustian, A. D., Sansom, M. S., Watts, A. & Fischer, W. B. Bundles consisting of extended transmembrane segments of Vpu from HIV 1: computer simulations and conductance measurements. Biochemistry 41, 7359-7365 (2002).
106. Kueck, T. & Neil, S. J. A. Cytoplasmic tail determinant in HIV 1 Vpu mediates targeting of tetherin for endosomal degradation and counteracts interferon-induced restriction. PLoS Pathog. 8, e1002609 (2011).
107. Magadan, J. G. & Bonifacino, J. S. Transmembrane domain determinants of CD4 downregulation by HIV 1 Vpu. J. Virol. 86, 757-772 (2012).
108. Iwabu, Y. et al. HIV 1 accessory protein Vpu internalizes cell-surface BST 2/tetherin through transmembrane interactions leading to lysosomes. J. Biol. Chem. 284, 35060-35072 (2009).
109. Perez-Caballero, D. et al. Tetherin inhibits HIV 1 release by directly tethering virions to cells. Cell 139, 499-511 (2009).
110. Evans, D. T., Serra-Moreno, R., Singh, R. K. & Guatelli, J. C. BST 2/tetherin: a new component of the innate immune response to enveloped viruses. Trends Microbiol. 18, 388-396 (2010).
111. Neil, S. J., Sandrin, V., Sundquist, W. I. & Bieniasz, P. D. An interferon-alpha-induced tethering mechanism inhibits HIV 1 and Ebola virus particle release but is counteracted by the HIV 1 Vpu protein. Cell Host Microbe 2, 193-203 (2007).
112. Acharya, R. et al. Structure and mechanism of proton transport through the transmembrane tetrameric M2 protein bundle of the influenza A virus. Proc. Natl Acad. Sci. USA 107, 15075-15080 (2010).
113. Moffat, J. C. et al. Proton transport through influenza A virus M2 protein reconstituted in vesicles. Biophys. J. 94, 434-445 (2008).
114. Stouffer, A. L. et al. Structural basis for the function and inhibition of an influenza virus proton channel. Nature 451, 596-599 (2008).
115. Lu, J. X., Sharpe, S., Ghirlando, R., Yau, W. M. & Tycko, R. Oligomerization state and supramolecular structure of the HIV 1 Vpu protein transmembrane segment in phospholipid bilayers. Protein Sci. 19, 1877-1896 (2010).
116. Lopez, C. F., Montal, M., Blasie, J. K., Klein, M. L. & Moore, P. B. Molecular dynamics investigation of membrane-bound bundles of the channel-forming transmembrane domain of viral protein U from the human immunodeficiency virus HIV 1. Biophys. J. 83, 1259-1267 (2002).
117. Cook, G. A. & Opella, S. J. Secondary structure, dynamics, and architecture of the p7 membrane protein from hepatitis C virus by NMR spectroscopy. Biochim. Biophys. Acta 1808, 1448-1453 (2011).
118. Kendal, A. P. & Klenk, H. D. Amantadine inhibits an early, M2 protein-dependent event in the replication cycle of avian influenza (H7) viruses. Arch. Virol. 119, 265-273 (1991).
119. StGelais, C. et al. Inhibition of hepatitis C virus p7 membrane channels in a liposome-based assay system. Antiviral Res. 76, 48-58 (2007).
120. Govorkova, E. A. & Webster, R. G. Combination chemotherapy for influenza. Viruses 2, 1510-1529 (2010).
121. Foster, T. L. et al. Resistance mutations define specific antiviral effects for inhibitors of the hepatitis C virus p7 ion channel. Hepatology 54, 79-90 (2011).
122. van Soest, H. et al. No beneficial effects of amantadine in treatment of chronic hepatitis C patients. Dig. Liver Dis. 42, 496-502 (2010).
123. Pawlotsky, J. M., Chevaliez, S. & McHutchison, J. G. The hepatitis C virus life cycle as a target for new antiviral therapies. Gastroenterology 132, 1979-1998 (2007).
124. Wilson, L., Gage, P. & Ewart, G. Hexamethylene amiloride blocks E protein ion channels and inhibits coronavirus replication. Virology 353, 294-306 (2006).
125. Luscombe, C. A. et al. A novel Hepatitis C virus p7 ion channel inhibitor, BIT225, inhibits bovine viral diarrhea virus in vitro and shows synergism with recombinant interferon-α 2b and nucleoside analogues. Antiviral Res. 86, 144-153 (2010).
126. Khoury, G., Ewart, G., Luscombe, C., Miller, M. & Wilkinson, J. Antiviral efficacy of the novel compound BIT225 against HIV 1 release from human macrophages. Antimicrob. Agents Chemother. 54, 835-845 (2010).
127. Xie, S. Q. et al. DIDS blocks a chloride-dependent current that is mediated by the 2B protein of enterovirus 71. Cell Res. 21, 1271-1275 (2011).
128. Gervais, C. et al. Development and validation of a high-throughput screening assay for the hepatitis C virus p7 viroporin. J. Biomol. Screen 16, 363-369 (2011).
129. Raghava, S., Giorda, K. M., Romano, F. B., Heuck, A. P. & Hebert, D. N. The SV40 late protein VP4 is a viroporin that forms pores to disrupt membranes for viral release. PLoS Pathog. 7, e1002116 (2011).
130. Wetherill, L. F. et al. High-risk human papillomavirus E5 oncoprotein displays channel-forming activity sensitive to small-molecule inhibitors. J. Virol. 86, 5341-5351 (2012).
131. Machamer, C. E. & Youn, S. The transmembrane domain of the infectious bronchitis virus E protein is required for efficient virus release. Adv. Exp. Med. Biol. 581, 193-198 (2006).
132. Ye, Y. & Hogue, B. G. Role of the coronavirus E viroporin protein transmembrane domain in virus assembly. J. Virol. 81, 3597-3607 (2007).
133. Tan, Y. J., Lim, S. G. & Hong, W. Regulation of cell death during infection by the severe acute respiratory syndrome coronavirus and other coronaviruses. Cell. Microbiol. 9, 2552-2561 (2007).
134. Plugge, B. et al. A potassium channel protein encoded by chlorella virus PBCV 1. Science 287, 1641-1644 (2000).
135. Wang, K., Xie, S. Q. & Sun, B. Viral proteins function as ion channels. Biochim. Biophys. Acta 1808, 510-515 (2011).
136. Gladue, D. P. et al. Classical swine fever virus p7 protein is a viroporin involved in virulence in swine. J. Virol. 86, 6778-6791 (2012).
137. Mould, J. A. et al. Influenza B virus BM2 protein has ion channel activity that conducts protons across membranes. Dev. Cell 5, 175-184 (2003).
138. Piller, S. C., Ewart, G. D., Premkumar, A., Cox, G. B. & Gage, P. W. Vpr protein of human immunodeficiency virus type 1 forms cation-selective channels in planar lipid bilayers. Proc. Natl Acad. Sci. USA 93, 111-115 (1996).
139. Silic-Benussi, M., Marin, O., Biasiotto, R., D'Agostino, D. M. & Ciminale, V. Effects of human T cell leukemia virus type 1 (HTLV 1) p13 on mitochondrial K+ permeability: a new member of the viroporin family? FEBS Lett. 584, 2070-2075 (2010).